about
The "Statinth" wonder of the world: a panacea for all illnesses or a bubble about to burst.Debate: Should statin be used in patients with heart failure?Debate: Statins should be used in patients with heart failureStatins in heart failure: do we need another trial?The Efficacy of Oral Nutritional Intervention in Malnourished Cancer Patients: a Systemic ReviewReverse Epidemiology of Traditional Cardiovascular Risk Factors in the Geriatric PopulationStatins in the treatment of chronic heart failure: a systematic reviewPharmacokinetics of drugs in cachectic patients: a systematic reviewObesity and Kidney Disease: Hidden Consequences of the Epidemic.Obesity paradox in group 1 pulmonary hypertension: analysis of the NIH-Pulmonary Hypertension registryRacial and ethnic differences in the association of body mass index and survival in maintenance hemodialysis patientsAssociations of body mass index and weight loss with mortality in transplant-waitlisted maintenance hemodialysis patients.Peripartum cardiomyopathy: an intriguing challenge. Case report with literature review.Animal models of anorexia and cachexia.Serum Concentration of HDL Particles Predicts Mortality in Acute Heart Failure Patients.Is there a paradox in obesity?Nutritional and anti-inflammatory interventions in chronic heart failure.Why is protein-energy wasting associated with mortality in chronic kidney disease?Cag pathogenicity island-specific responses of gastric epithelial cells to Helicobacter pylori infectionThe importance of the gastrointestinal system in the pathogenesis of heart failure.Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients.Pre-morbid body mass index and mortality after incident heart failure: the ARIC Study.Inflammatory mediators in chronic heart failure: an overviewHigh cholesterol may protect against infections and atherosclerosis.Short-term statin treatment improves endothelial function and neurohormonal imbalance in normocholesterolaemic patients with non-ischaemic heart failure.Quantitative lipopolysaccharide analysis using HPLC/MS/MS and its combination with the limulus amebocyte lysate assay.Effects of Statin Therapy on Clinical Outcomes of Survivors of Acute Myocardial Infarction with Severe Systolic Heart FailureCardiac cachexia.Reverse epidemiology: a spurious hypothesis or a hardcore reality?The Association of Metabolic Syndrome with Diabetic Retinopathy: The Korean National Health and Nutrition Examination Survey 2008-2012.Future prospects of anticytokine therapy in chronic heart failure.Ventricular assist device implantation corrects myocardial lipotoxicity, reverses insulin resistance, and normalizes cardiac metabolism in patients with advanced heart failureSerum Total Cholesterol Levels Would Predict Nosocomial Infections After Gastrointestinal Surgery.Emerging drugs for the treatment of sepsis.Obesity paradox in end-stage kidney disease patients.Viewpoint: the prothrombotic state in heart failure: a maladaptive inflammatory response?The kidney disease wasting: inflammation, oxidative stress, and diet-gene interaction.Primary and secondary prevention of heart failure with statins.Emerging drugs for acute and chronic heart failure: current and future developments.Atorvastatin and statins in the treatment of heart failure.
P2860
Q24796000-5DA1DF25-2760-499F-A0A7-95F09763B95DQ24799305-5FC7A539-7984-4D51-BC80-6CFD27D2BDCEQ24799320-6795F7EF-5D9E-4A51-9715-0120C8DF5801Q26998966-BF1E9FE8-FA9A-4D01-B5EA-901633DDA6B8Q28068895-77E4F826-BC19-4517-88CA-FEBC56C54E23Q28081914-2B7C6CFC-9E65-46BD-8B44-E85850989F8CQ28200294-B6F57467-4C2F-4D6F-909F-303A3FC5280FQ28535322-C71394E0-E8CF-4C5A-8578-C6BA8511F8C9Q30235506-E3CD86C2-F475-4A70-8F98-2F25F4549E5CQ30274745-317605BC-E528-42A0-A68C-1DCE26C742E0Q30424662-E230BBEB-508A-4684-8346-BCBD3CF0F7CAQ30427552-9C99FDC0-5DB6-43D2-A5CA-C10DBC35935AQ30434271-C100A163-76B2-4B55-A3EF-24AB7615EB84Q30434298-C0A99467-1660-41A9-8FE8-D92C5F6A2B7AQ33572720-379A25BF-EEFD-4404-A5FB-451D8D4B6E61Q33724123-DEBDD115-E97C-44D8-BE9B-59CDF026D42BQ33880185-A233E19A-2B00-44C5-9ADD-C409FAC4A376Q33882103-1621573D-7AAC-4F37-BBEB-D9531FE72CB6Q34381529-3E0622A8-41E8-4041-A5B8-D429AE469652Q34429097-8B5BF340-B36F-4267-8026-9C4EE58DEFF3Q34448604-DF3849F9-F5CA-498A-BCE8-636A48A54608Q34789650-AA9B6D0E-7547-4513-B7E2-04CACA41A056Q35582235-7C49ECAB-13BD-4DD7-9BB0-EF14E6D0B7AEQ35590201-2CC04B32-96CB-47F4-AA9D-7C6D2E81DF1AQ35772664-D238E229-2830-43FC-AE64-FFDBC2370834Q35776664-431A1F12-C240-40DD-92CD-B1E629FA9B6AQ35866965-A470FEB7-3A96-474E-8D24-6BEEADEB1CB7Q35932382-CE1304D2-7309-49CE-B93D-41665775AEA9Q35997678-C1FCE2A0-E45C-4920-A4A1-F113BE7BB012Q36044969-3431334D-4C5C-454C-9CAA-D9C8477538F1Q36087238-DD1994CE-8ED2-4569-9C00-F83603594786Q36298248-E3681824-63B9-4BAC-B01D-93D8CB6589D7Q36396239-16A5F3AC-932C-489E-A3E5-F41641DD8147Q36407391-0C7433F0-EA2F-4F95-B1A8-C21B65C070AEQ36522468-51E21A19-1742-48A9-824B-46CD34B3AE14Q36543429-CC431C49-BA6B-426F-88C2-A4CE5D2EF111Q36609845-9B583DE5-E904-4ED0-90F2-B433449ECDAFQ36686069-57BF3751-CB1C-403B-AB09-84FC7F11A321Q36758585-81B1F278-5E6B-40AA-8C6E-CE9103EA9110Q37000767-5DE93C0C-04A8-4A41-AFF1-0F4D11C9B18F
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The endotoxin-lipoprotein hypothesis.
@ast
The endotoxin-lipoprotein hypothesis.
@en
The endotoxin-lipoprotein hypothesis.
@nl
type
label
The endotoxin-lipoprotein hypothesis.
@ast
The endotoxin-lipoprotein hypothesis.
@en
The endotoxin-lipoprotein hypothesis.
@nl
prefLabel
The endotoxin-lipoprotein hypothesis.
@ast
The endotoxin-lipoprotein hypothesis.
@en
The endotoxin-lipoprotein hypothesis.
@nl
P2093
P1433
P1476
The endotoxin-lipoprotein hypothesis.
@en
P2093
P304
P356
10.1016/S0140-6736(00)02690-8
P407
P577
2000-09-01T00:00:00Z